2001
DOI: 10.1034/j.1600-0455.2001.042001080.x
|View full text |Cite
|
Sign up to set email alerts
|

PERCUTANEOUS TRANSCATHETER RENAL EMBOLIZATION WITH ABSOLUTE ETHANOL FOR UNCONTROLLED NEPHROTIC SYNDROME. Case reports

Abstract: Permanent bilateral ethanol embolization of the renal arteries is a feasible method of managing a treatment-resistant nephrotic syndrome in selected patients. Non-target embolization can be avoided by using a balloon occlusion catheter.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 14 publications
0
8
0
Order By: Relevance
“…2). Because of the successful outcome in this case and previous reports [3, 4, 5, 6, 7, 8, 9, 10, 11], it is suggested that treatment with bilateral RAE as early as possible may be worthwhile for patients with severe proteinuria resistant to medical therapy.…”
Section: Discussionmentioning
confidence: 50%
See 2 more Smart Citations
“…2). Because of the successful outcome in this case and previous reports [3, 4, 5, 6, 7, 8, 9, 10, 11], it is suggested that treatment with bilateral RAE as early as possible may be worthwhile for patients with severe proteinuria resistant to medical therapy.…”
Section: Discussionmentioning
confidence: 50%
“…No specific complications arose as a result of the regular HD. This case and selected previous reports [3, 4, 5, 6, 7, 8, 9, 10, 11] reveal important information for physicians and patients in discussing prognoses and considering the pros and cons of bilateral RAE.…”
Section: Discussionmentioning
confidence: 67%
See 1 more Smart Citation
“…RAE for treatment‐refractory, amyloidosis‐associated nephrotic syndrome has been reported in several case studies since the 1980s . However, these experiences mainly focused on AA‐amyloidosis resulting from underlying inflammatory diseases (Table ) . Reports on RAE use in MGRS‐associated AL‐amyloidosis remain limited, but require particular consideration as they are caused by a malignant B‐cell clone that typically demands intense anti‐tumoral treatment …”
Section: Discussionmentioning
confidence: 99%
“…[12][13][14] However, these experiences mainly focused on AA-amyloidosis resulting from underlying inflammatory diseases (Table 1). [14][15][16][17] Reports on RAE use in MGRS-associated AL-amyloidosis remain limited, but require particular consideration as they are caused by a malignant B-cell clone that typically demands intense anti-tumoral treatment. 18 A recent analysis from the Mayo group on a cohort of 66 patients with monoclonal immunoglobulin deposition disease reported that renal response may be observed in…”
Section: Discussionmentioning
confidence: 99%